The risk factors for tardive dyskinesia in patients taking antipsychotics include age, comorbid diagnoses, and high medication dosages.
Variation in autism spectrum disorder occurrence may be due to genetic influences, rather than maternal or environmental effects.
Prenatal opioid exposure may be associated with poorer cognitive and motor development in children from age 6 months to adolescence.
Top-down regulatory mechanisms influenced whether or not children with autism spectrum disorder expressed atypical behavioral responses to sensory stimuli.
Adhansia XR (methylphenidate HCl extended-release capsules) for the treatment of attention deficit hyperactivity disorder in patients aged 6 years and older, has launched.
Current guidelines include recommendations on how to prescribe methylphenidate, but lack of recommendations regarding the long-term use of the drug.
Adhansia XR (methylphenidate HCl extended-release capsules) is expected to be available as of July 15, 2019 for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years of age and older, according to Adlon Therapeutics.
Researchers sought to determine risk factors for hospitalization in children with atopic dermatitis.
Self-experience could be valuable when clinically differentiating between schizotypal disorder and autism spectrum disorder.
Researchers found that a toddler diagnosed with autism spectrum disorder is unlikely to test within typical levels at age 3 years.